Submission Details
| 510(k) Number | K122380 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2012 |
| Decision Date | November 07, 2012 |
| Days to Decision | 93 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K122380 is an FDA 510(k) clearance for the OCELOT SYSTEM. This device is classified as a Catheter For Crossing Total Occlusions (Class II — Special Controls, product code PDU).
Submitted by Avinger, Inc. (Redwood City, US). The FDA issued a Cleared decision on November 7, 2012, 93 days after receiving the submission on August 6, 2012.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250. To Facilitate The Intraluminal Placement Of Conventional Guidewires Beyond Stenotic Lesions (including Subchronic And Chronic Total Occlusions) In The Peripheral Vasculature Prior To Further Percutaneous Intervention, Such As Angioplasty, Atherectomy Or Stent Placement..
| 510(k) Number | K122380 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2012 |
| Decision Date | November 07, 2012 |
| Days to Decision | 93 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | PDU — Catheter For Crossing Total Occlusions |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | To Facilitate The Intraluminal Placement Of Conventional Guidewires Beyond Stenotic Lesions (including Subchronic And Chronic Total Occlusions) In The Peripheral Vasculature Prior To Further Percutaneous Intervention, Such As Angioplasty, Atherectomy Or Stent Placement. |